Gene · 3937
Papers1,973
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 1,973
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Aging-associated HELIOS deficiency in naive CD4+ T cells alters chromatin remodeling and promotes effector cell responses. | Nat Immunol | 2023 | 36510022 | PubTator, text mining | PubMed |
| SLP76 Mutation Associated with Combined Immunodeficiency and EBV-Related Lymphoma. | J Clin Immunol | 2023 | 36474126 | PubTator, text mining | PubMed |
| The diagnosis of severe combined immunodeficiency (SCID): The Primary Immune Deficiency Treatment Consortium (PIDTC) 2022 Definitions. | J Allergy Clin Immunol | 2023 | 36456361 | PubTator, text mining | PubMed |
| Clonal lineage tracing reveals mechanisms skewing CD8+ T cell fate decisions in chronic infection. | J Exp Med | 2023 | 36315049 | PubTator, text mining | PubMed |
| Sialylated IgG in epithelial cancers inhibits antitumor function of T cells via Siglec-7. | Cancer Sci | 2023 | 36310398 | PubTator, text mining | PubMed |
| KIR3DL3-HHLA2 and TMIGD2-HHLA2 pathways: The dual role of HHLA2 in immune responses and its potential therapeutic approach for cancer immunotherapy. | J Adv Res | 2023 | 35933091 | PubTator, text mining | PubMed |
| TNK2/ACK1-mediated phosphorylation of ATP5F1A (ATP synthase F1 subunit alpha) selectively augments survival of prostate cancer while engendering mitochondrial vulnerability. | Autophagy | 2023 | 35895804 | PubTator, text mining | PubMed |
| Inflamed and non-inflamed classes of HCC: a revised immunogenomic classification. | Gut | 2023 | 35197323 | PubTator, text mining | PubMed |
| MS4A3-HSP27 target pathway reveals potential for haematopoietic disorder treatment in alimentary toxic aleukia. | Cell Biol Toxicol | 2023 | 34581912 | PubTator, text mining | PubMed |
| Current state of NK cell-mediated immunotherapy in chronic lymphocytic leukemia. | Front Oncol | 2022 | 37078002 | PubTator, text mining | PubMed |
| ABI3BP is a prognosis biomarker related with clinicopathological features and immunity infiltration of lung tumor. | Front Genet | 2022 | 36744181 | PubTator, text mining | PubMed |
| Regulation of CD45 phosphatase by oncogenic ALK in anaplastic large cell lymphoma. | Front Oncol | 2022 | 36698412 | PubTator, text mining | PubMed |
| Immune activation of characteristic gut mycobiota Kazachstania pintolopesii on IL-23/IL-17R signaling in ankylosing spondylitis. | Front Cell Infect Microbiol | 2022 | 36605130 | PubTator, text mining | PubMed |
| Identification of hub genes correlated with tumor-associated M1-like macrophage infiltration in soft tissue sarcomas. | Front Genet | 2022 | 36561315 | PubTator, text mining | PubMed |
| SH2 Domains: Folding, Binding and Therapeutical Approaches. | Int J Mol Sci | 2022 | 36555586 | PubTator, text mining | PubMed |
| The Functional Properties and Physiological Roles of Signal-Transducing Adaptor Protein-2 in the Pathogenesis of Inflammatory and Immune Disorders. | Biomedicines | 2022 | 36551835 | PubTator, text mining | PubMed |
| Single-cell transcriptomic analysis reveals differential cell subpopulations and distinct phenotype transition in normal and dissected ascending aorta. | Mol Med | 2022 | 36536281 | PubTator, text mining | PubMed |
| Longitudinal transcriptional analysis of peripheral blood leukocytes in COVID-19 convalescent donors. | J Transl Med | 2022 | 36510222 | PubTator, text mining | PubMed |
| Genetic Heterogeneity, Tumor Microenvironment and Immunotherapy in Triple-Negative Breast Cancer. | Int J Mol Sci | 2022 | 36499265 | PubTator, text mining | PubMed |
| Joining Forces for Cancer Treatment: From "TCR versus CAR" to "TCR and CAR". | Int J Mol Sci | 2022 | 36498890 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3937/papers?page=13